Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis*-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Multicenter, double-blind, placebo-controlled study of the use of filgrastim in patients hospitalized with pneumonia and severe sepsis*

Published:2003-02 Issue:2 Volume:31 Page:367-373
ISSN:0090-3493
Container-title:Critical Care Medicine
language:en
Short-container-title:Critical Care Medicine

Author:

Root Richard K.,Lodato Robert F.,Patrick Ward,Cade John Francis,Fotheringham Nick,Milwee Steven,Vincent Jean-Louis,Torres Antonio,Rello Jordi,Nelson Steve

Publisher

Ovid Technologies (Wolters Kluwer Health)

Subject

Critical Care and Intensive Care Medicine

Reference33 articles.

1. Epidemiology of severe sepsis in the United States: Analysis of incidence, outcome, and associated costs of care

2. Anti-inflammatory therapies to treat sepsis and septic shock

3. Treating Patients with Severe Sepsis

4. Incidence of Community-Acquired Pneumonia Requiring Hospitalization

5. A Question of Balance

Cited by 156 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Neutropenia febbrile in Pronto Soccorso;EMC - Urgenze;2023-06

2. Extracorporeal therapy of sepsis by purified granulocyte concentrates: ex vivo circulation model;Artificial Organs;2023-02-14

3. Beneficial Immune Regulation by Biological Response Modifier Glucans in COVID-19 and Their Envisaged Potentials in the Management of Sepsis;Frontiers in Immunology;2022-06-27

4. Identification of deleterious neutrophil states and altered granulopoiesis in sepsis;2022-03-23

5. Dysregulated Immunity and Immunotherapy after Sepsis;Journal of Clinical Medicine;2021-04-17

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP